Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Start your intake Why GLP-1 Safety Data Remains Limited in Lactation GLP-1 receptor agonists (semaglutide, tirzepatide, retatrutide) were not studied in breastfeeding populations during clinical development
Important safety considerations include: tirzepatide is not indicated for type 1 diabetes or treatment of diabetic ketoacidosis, and it is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
2007;293:E6049
You can inject the medication under the skin of your abdomen, thighs, or upper arm
Using multiple pharmacies can be both an advantage and a disadvantage
Sample size was determined based on practical considerations, prior experience with similar phase 1 study designs, and the objective of obtaining sufficient safety and pharmacokinetic data to support dose escalation decisions
